Burleson Tess 4
4 · Salarius Pharmaceuticals, Inc. · Filed Mar 25, 2020
Insider Transaction Report
Form 4
Burleson Tess
Director
Transactions
- Award
Stock Option (right to buy)
2020-03-23+6,000→ 6,000 totalExercise: $0.61Exp: 2030-03-22→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]Options granted are fully vested on March 23, 2021.